Abnormal activation of AT1 is associated with cardiovascular disease, inflammation and atherosclerosis, endothelial dysfunction, oxidative stress, insulin resistance, cancer and malignant hypertension. This evidence concerns the gene AGTR1 and Insulin resistance.